600538.SH
国发股份
SSE · Healthcare · Medical - Pharmaceuticals · CN
CNY 5.13
−1.54%Margins
Gross margin
23.2%
EBITDA margin
-20.8%
EBIT margin
-28.8%
Net margin
-29.6%
FCF margin
-7.3%
-14.5%
Return on equity
-11.2%
Return on assets
-13.1%
Return on invested capital
0.37x
Asset turnover
-CNY 18.6M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026